98%
921
2 minutes
20
Efficient processing of radiology reports for monitoring disease progression is crucial in oncology. Although large language models (LLMs) show promise in extracting structured information from medical reports, privacy concerns limit their clinical implementation. This study evaluates the feasibility and accuracy of two of the most recent Llama models for generating structured lymphoma progression reports from cross-sectional imaging data in a privacy-preserving, real-world clinical setting. This single-center, retrospective study included adult lymphoma patients who underwent cross-sectional imaging and treatment between July 2023 and July 2024. We established a chain-of-thought prompting strategy to leverage the locally deployed Llama-3.3-70B-Instruct and Llama-4-Scout-17B-16E-Instruct models to generate lymphoma disease progression reports across three iterations. Two radiologists independently scored nodal and extranodal involvement, as well as Lugano staging and treatment response classifications. For each LLM and task, we calculated the F1 score, accuracy, recall, precision, and specificity per label, as well as the case-weighted average with 95% confidence intervals (CIs). Both LLMs correctly implemented the template structure for all 65 patients included in this study. Llama-4-Scout-17B-16E-Instruct demonstrated significantly greater accuracy in extracting nodal and extranodal involvement information (nodal: 0.99 [95% CI = 0.98-0.99] vs. 0.97 [95% CI = 0.95-0.96], p < 0.001; extranodal: 0.99 [95% CI = 0.99-1.00] vs. 0.99 [95% CI = 0.98-0.99], p = 0.013). This difference was more pronounced when predicting Lugano stage and treatment response (stage: 0.85 [95% CI = 0.79-0.89] vs. 0.60 [95% CI = 0.53-0.67], p < 0.001; treatment response: 0.88 [95% CI = 0.83-0.92] vs. 0.65 [95% CI = 0.58-0.71], p < 0.001). Neither model produced hallucinations of newly involved nodal or extranodal sites. The highest relative error rates were found when interpreting the level of disease after treatment. In conclusion, privacy-preserving LLMs can effectively extract clinical information from lymphoma imaging reports. While they excel at data extraction, they are limited in their ability to generate new clinical inferences from the extracted information. Our findings suggest their potential utility in streamlining documentation and highlight areas requiring optimization before clinical implementation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s10278-025-01618-z | DOI Listing |
Retin Cases Brief Rep
October 2024
Eye Clinic, Humanitas-Gradenigo Hospital, Torino, Italy.
Purpose: To study the efficacy and safety of pro re nata regimen of brolucizumab, without loading dose, in treatment-naive patients with neovascular age-related macular degeneration (nAMD).
Case Series: Retrospective, observational study. We included all consecutive patients diagnosed with treatment- naïve nAMD undergoing Brolucizumab in Humanitas eye clinic, Turin, Italy between April 2022 and May 2023.
J Clin Ultrasound
September 2025
Division of Pediatric Surgery, Federico II University Hospital, Naples, Italy.
Paratesticular rhabdomyosarcoma (RMS) is a rare pediatric malignancy often misdiagnosed as benign conditions like epididymitis. We report a 4-year-old boy with paratesticular RMS and retroperitoneal metastasis, initially mistaken for epididymitis. The diagnostic delay resulted in disease progression, necessitating radical inguinal orchiectomy, hemiscrotectomy, and complete multimodal therapy.
View Article and Find Full Text PDFEur J Case Rep Intern Med
August 2025
Charleston Area Medical Center, Charleston, USA.
Introduction: species, particularly , are rare opportunistic pathogens that typically affect immunocompromised individuals. These infections usually present with respiratory or systemic symptoms and are often linked to environmental exposure. Asymptomatic infections are exceedingly rare and pose unique diagnostic and therapeutic challenges.
View Article and Find Full Text PDFEur J Case Rep Intern Med
August 2025
General medicine department, Universidad de Cartagena, Cartagena, Colombia.
Background: Romosozumab is a sclerostin-inhibiting monoclonal antibody that is effective and safe for anabolic treatment in patients with osteoporosis. Its main adverse effects are local; the severity of these injection-site reactions in clinical trials was generally mild.
Case Report: We present a case of a 71-year-old Colombian woman with osteoporosis at very high risk of fractures with no relevant history of drug allergies.
Eur J Case Rep Intern Med
August 2025
Department of Internal Medicine, Local Health Unit of São João, Porto, Portugal.
Unlabelled: Bariatric surgery has emerged as a highly effective treatment option for individuals with obesity. Severe hypoalbuminaemia is a feared complication after a Roux-en-Y gastric bypass. It is characterised by a low serum albumin level of <25 g/l, neither explained by renal losses, protein-losing enteropathy nor by liver disfunction, and is associated with high morbidity and mortality.
View Article and Find Full Text PDF